Robert Coury, executive chairman of  Mylan pharmacutical company with Taoiseach Enda Kenny in 2012 announcing more than 500 jobs between plants at Baldoyle in Dublin and Galway.Photograph: Alan Betson / The Irish Times

Drugmaker Mylan posted a 17 per cent rise in quarterly revenue, helped by higher generic drug sales, and stood by its full-year revenue and adjusted p(...)

Ferrari: results are out today

TODAY Results: Ferrari. Indicators: UK Halifax house price index (Apr); Euro zone Markit manufacturing PMI (Apr); German Markit manufacturing PMI ((...)

Joe Papa (above) has been tapped by rival Valeant to fill the shoes vacated by Canadian Mike Pearson. Photograph: Brenda Fitzsimons / The Irish Times

Perrigo, the over-the-counter drugs specialist that moved its domicile to Ireland when it took over the rump of Elan’s business in 2013, is losing its(...)

Drugmaker Perrigo is to replace chief executive  Joseph Papa with president John Hendrickson (pictured) the company said on Monday. Papa will join rival  Valeant Pharmaceuticals International Inc. as CEO. (Phootgraph: Amir Cohen/Reuters)

Valeant Pharmaceuticals named Joseph Papa as its chief executive on Monday, the day after he resigned from the top spot at drugmaker Perrigo. The m(...)

Perrigo chief executive Joe Papa

While many companies pay bonuses when executives make a deal to sell their business, Dublin-based Perrigo’s executives also got paid not to. After su(...)

 Mylan first tried to buy Meda in 2014, but its offer was rejected. Photograph: Travis Dove/The New York Times

Mylan, the generic drugmaker, is poised to announce a takeover of Sweden’s Meda, according to people briefed on the deal. The takeover of Meda would h(...)

US drugmakers have been under increased pressure from the government, insurers and corporations over steep increases in the prices of generic drugs. Photograph:  Vladimir Nenov/Getty Images/iStockphoto

The antitrust division of the US department of justice has subpoenaed Mylan for information relating to the pricing and marketing of its generic doxyc(...)

Mylan, which first made a bid for Perrigo in April, went hostile in September, offering $75 in cash and 2.3 of its shares for each Perrigo share

Generic drug maker Mylan said on Friday that 40 per cent of Perrigo ’s shares were tendered in its $26 billion hostile takeover offer, falling short o(...)

Joe Papa chief executive nd president of Perrigo photographed in the former Elan offices in the Treasury Building, Dublin. Photograph: Brenda Fitzsimons / The Irish Times

Mylan has said an Israeli district court has ruled against target Perrigo ’s attempt to block Mylan’s listing on the Tel Aviv Stock Exchange. A Tel Av(...)

Joe Papa CEO and President of Perrigo said shareholders are unlikely to accept a hostile $27.1 billion takeover bid from Mylan.  (Photograph: Brenda Fitzsimons / THE IRISH TIMES)

Perrigo chief executive officer Joseph Papa said shareholders are unlikely to accept a hostile $27.1 billion takeover bid from Mylan. Papa, who(...)